More than 700 registrars at the Kenyatta National Hospital (KNH) have downed their tools following suspension of one of their own over the brain surgery mishap.
The master’s students said they would not resume work until the largest referral hospital in the country resolves systemic issues.
According to the registrars, they boycotted work for unwarranted victimisation of one of their colleagues who was sent home following a mix-up in identification tags during the brain surgery.
They held a meeting with officials of the Kenya Medical Pharmacists and Dentists Union (KMPDU) on Monday morning.
KMPDU Secretary General Dr Ouma Oluga, released a statement blaming the incident on systemic failures in the hospital.
“In a Health Stakeholders meeting, the clinical officers, through their union, have categorically condemned and rejected the ‘Multi-Tasking, task shifting, task sharing’ policy from Ministry of Health and we at KMPDU totally agree and support this move.
“We have deliberated about the suspension of the neurosurgeons; We call on the KNH board to reinstate them unconditionally. Over 700 registrars working at KNH will no longer offer services until issues have been sorted out,” Dr Oluga said.
A registrar is a doctor who is undergoing further training in a specialised field of medicine in order to become a consultant.
The National Nurses Association of Kenya on Saturday asked medics at KNH to stop blaming nurses for the brain surgery mishap and take full responsibility.
The association Chairman Alfred Obengo, said that a doctor prescribes a surgery and can only be done on a patient the doctor has met.
“We shall take responsibility if a nurse is found responsible but we need whoever is responsible to take responsibility.
“How possible is it for the surgeon to carry out an operation on a patient they have not met before? Does it mean they operate on whoever is brought to them without confirmation?” Obengo asked.
Health Cabinet Secretary Sicily Kariuki suspended CEO Lily Koros and directed the Board of Directors to appoint a new CEO in an Acting Capacity.
The Acting CEO Dr Thomas Mutie was appointed during a Saturday board meeting, with Dr Peter Masinde as acting director of clinical services taking over from Dr Ben Githae who was also sent on compulsory leave.